Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, Vasovagal Symptoms, Smoking Tendency, and Treatment Effects in Patients Referred for Sleep Study

What this Trial Is About

Researchers are studying patients referred for sleep studies at Jordan University Hospital and Jordan Hospital, including those using at-home sleep study kits. This study aims to collect demographic and clinical data to evaluate the connection between obstructive sleep apnea (OSA), facial discoloration, vasovagal symptoms, and smoking habits. It also investigates how treatment for OSA affects these factors and the timing of symptom appearance related to smoking initiation. Participants will undergo a physical exam to assess facial discoloration, which will be graded by severity and photographed with consent. Sleep studies will be performed either in-lab using polysomnography or at home with a sleep study device. OSA severity will be classified by the apnea-hypopnea index (AHI). Those with positive sleep study results will be followed up at 3 weeks and 6 months to monitor treatment, symptom improvement, smoking habits, and vasovagal symptoms. Participants with negative results will also be followed for changes in smoking and vasovagal symptoms. Participants will be interviewed at their initial visit to collect medical history and smoking information, and their faces examined and photographed for discoloration. Follow-up will occur in clinic or by phone and email at 3 weeks and 6 months. Data analysis will assess the relationships between OSA, facial discoloration, vasovagal symptoms, smoking tendency, and treatment effects. Confidentiality and consent are ensured, and participants' treatment plans will not be altered during the study.

Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.